Ana Franco-Villanueva

Ana Franco-Villanueva

Auto-generated profile, based on publicly available information

Ana Franco-Villanueva

Department of Pharmacology and Systems Physiology, University of Cincinnati

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
BMBrent Myers
Brent Myers
JSJessie R. Scheimann
Jessie R. Scheimann
AFAna Franco-Villanueva
Ana Franco-Villanueva
JHJames P. Herman
James P. Herman

1 February 2011 in European Journal of Cell Biology
Verified
Journal Article
Closed access
IBInmaculada Bañón-Rodríguez
Inmaculada Bañón-Rodríguez
JMJames Monypenny
James Monypenny
CRChiara Ragazzini
Chiara Ragazzini
AFAna Franco
Ana Franco
YCYolanda Calle
Yolanda Calle
IAInés M. Antón
Inés M. Antón

21 February 2012 in PLOS Biology
Verified
Journal Article
Open access
PDF file
SKShira Knafo
Shira Knafo
CVCésar Venero
César Venero
CSCristina Sánchez-Puelles
Cristina Sánchez-Puelles
IPInmaculada Pereda-Peréz
Inmaculada Pereda-Peréz
AFAna Franco
Ana Franco
JEJosé A. Esteban
José A. Esteban
Cell adhesion molecules and downstream growth factor-dependent signaling are critical for brain development and synaptic plasticity, and they have been linked to cognitive function in adult animals. We have previously developed a mimetic peptide (FGL) from the neural cell adhesion molecule (NCAM) that enhances spatial learning and memory in rats. We have now investigated the cellular and molecular basis of this cognitive enhancement, using biochemical, morphological, electrophysiological, and behavioral analyses. We have found that FGL triggers a long-lasting enhancement of synaptic transmission in hippocampal CA1 neurons. This effect is mediated by a facilitated synaptic delivery of AMPA receptors, which is accompanied by enhanced NMDA receptor-dependent long-term potentiation (LTP). Both LTP and cognitive enhancement are mediated by an initial PKC activation, which is followed by persistent CaMKII activation. These results provide a mechanistic link between facilitation of AMPA receptor synaptic delivery and improved hippocampal-dependent learning, induced by a pharmacological cognitive enhancer. The human brain contains trillions of neuronal connections, called synapses, whose pattern of activity controls all our cognitive functions. These synaptic connections are dynamic and constantly changing in their strength and properties, and this process of synaptic plasticity is essential for learning and memory. Alterations in synaptic plasticity mechanisms are thought to be responsible for multiple cognitive deficits, such as autism, Alzheimer's disease, and several forms of mental retardation. In this study, we show that synapses can be made more plastic using a small protein fragment (peptide) derived from a neuronal protein involved in cell-to-cell communication. This peptide (FGL) initiates a cascade of events inside the neuron that results in the facilitation of synaptic plasticity. Specifically, we find that FGL triggers delivery of a specific type of glutamate receptor (AMPA receptors) to synapses in a region of the brain called the hippocampus, which is known to be involved in multiple forms of learning and memory. Importantly, when this peptide was administered to rats, their ability to learn and retain spatial information was enhanced. Therefore, this work demonstrates that cognitive function can be improved pharmacologically in adult animals by enhancing the plasticity of synaptic connections in the brain.

24 May 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AWAynara C Wulsin
Aynara C Wulsin
AFAna Franco-Villanueva
Ana Franco-Villanueva
CRChristian Romancheck
Christian Romancheck
RMRachel L Morano
Rachel L Morano
BSBrittany L Smith
Brittany L Smith
JHJames P Herman
James P Herman
Clinical data suggest that the neuroendocrine stress response is chronically dysregulated in a subset of patients with temporal lobe epilepsy (TLE), potentially contributing to both disease progression and the development of psychiatric comorbidities such as anxiety and depression. Whether neuroendocrine dysregulation and psychiatric comorbidities reflect direct effects of epilepsy-related pathologies, or secondary effects of disease burden particular to humans with epilepsy (i.e. social estrangement, employment changes) is not clear. Animal models provide an opportunity to dissociate these factors. Therefore, we queried whether epileptic mice would reproduce neuroendocrine and behavioral changes associated with human epilepsy. Male FVB mice were exposed to pilocarpine to induce status epilepticus (SE) and the subsequent development of spontaneous recurrent seizures. Morning baseline corticosterone levels were elevated in pilocarpine treated mice at 1, 7 and 10 weeks post-SE relative to controls. Similarly, epileptic mice had increased adrenal weight when compared to control mice. Exposure to acute restraint stress resulted in hypersecretion of corticosterone 30 min after the onset of the challenge. Anatomical analyses revealed reduced Fos expression in infralimbic and prelimbic prefrontal cortex, ventral subiculum and basal amygdala following restraint. No differences in Fos immunoreactivity were found in the paraventricular nucleus of the hypothalamus, hippocampal subfields or central amygdala. In order to assess emotional behavior, a second cohort of mice underwent a battery of behavioral tests, including sucrose preference, open field, elevated plus maze, 24h home-cage monitoring and forced swim. Epileptic mice showed increased anhedonic behavior, hyperactivity and anxiety-like behaviors. Together these data demonstrate that epileptic mice develop HPA axis hyperactivity and exhibit behavioral dysfunction. Endocrine and behavioral changes are associated with impaired recruitment of forebrain circuits regulating stress inhibition and emotional reactivity. Loss of forebrain control may underlie pronounced endocrine dysfunction and comorbid psychopathologies seen in temporal lobe epilepsy.

7 May 2014 in mAbs
Verified
Journal Article
Open access
SCSonia Chamorro
Sonia Chamorro
MVMaria Vela
Maria Vela
AFAna Franco-Villanueva
Ana Franco-Villanueva
LCLaura Carramolino
Laura Carramolino
JGJulio Gutiérrez
Julio Gutiérrez
LKLeonor Kremer
Leonor Kremer
Tumor expression of certain chemokine receptors is associated with resistance to apoptosis, migration, invasiveness and metastasis. Because CCR9 chemokine receptor expression is very restricted in ...

1 September 2020 in eneuro
Verified
Journal Article
Open access
PDF file
NNNawshaba Nawreen
Nawshaba Nawreen
ECEvelin M. Cotella
Evelin M. Cotella
RMRachel Morano
Rachel Morano
PMParinaz Mahbod
Parinaz Mahbod
KDKhushali S. Dalal
Khushali S. Dalal
JHJames P. Herman
James P. Herman
Hypofunction of the prefrontal cortex (PFC) contributes to stress-related neuropsychiatric illnesses. Mechanisms leading to prefrontal hypoactivity remain to be determined. Prior evidence suggests that chronic stress leads to an increase in activity of parvalbumin (PV) expressing GABAergic interneurons (INs) in the PFC. The purpose of the study was to determine whether reducing PV IN activity in the Infralimbic (IL) PFC would prevent stress-related phenotypes. We used a chemogenetic approach to inhibit IL PFC PV INs during stress. Mice were first tested in the tail suspension test (TST) to determine the impact of PV IN inhibition on behavioral responses to acute stress. The long-term impact of PV IN inhibition during a modified chronic variable stress (CVS) was tested in the forced swim test (FST). Acute PV IN inhibition reduced active (struggling) and increased passive coping behaviors (immobility) in the TST. In contrast, inhibition of PV INs during CVS increased active and reduced passive coping behaviors in the FST. Moreover, chronic inhibition of PV INs attenuated CVS-induced changes in Fos expression in the prelimbic cortex (PrL), basolateral amygdala (BLA), and ventrolateral periaqueductal gray (vlPAG) and also attenuated adrenal hypertrophy and body weight loss associated with chronic stress. Our results suggest differential roles of PV INs in acute versus chronic stress, indicative of distinct biological mechanisms underlying acute versus chronic stress responses. Our results also indicate a role for PV INs in driving chronic stress adaptation and support literature evidence suggesting cortical GABAergic INs as a therapeutic target in stress-related illnesses.